Markets:

Overview

News

Currencies

International

Treasuries

Gilead Sciences (NQ:GILD)

123.48 +2.12 (+1.75%)

Streaming Delayed Price Updated: 10:20 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Gilead Sciences

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

49 50 Next >

A Closer Look at Gilead Sciences's Options Market Dynamics ↗

November 09, 2023

Via Benzinga

Where Gilead Sciences Stands With Analysts ↗

November 09, 2023

Via Benzinga

Gilead Sciences Tops Q3 Earnings And Revenue Estimates ↗

November 07, 2023

While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

Via Talk Markets

Gilead Sciences (GILD) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

GILD earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Gilead Sciences Stock Slides After Hours On Q3 Report - Here's Why ↗

November 07, 2023

Gilead Sciences, Inc. (NASDAQ: GILD) shares are volatile in Tuesday's after-hours session on the heels of the company's

Via Benzinga

Gilead Squashes Expectations On The Back Of A Bullish Move For Its Cancer Drugs ↗

November 07, 2023

The biotech company makes three notable treatments for cancer.

Via Investor's Business Daily

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,200 Today ↗

November 06, 2023

Via Benzinga

This Is What Whales Are Betting On Gilead Sciences ↗

November 02, 2023

Via Benzinga

Comparative Study: Gilead Sciences And Industry Competitors In Biotechnology Industry ↗

October 20, 2023

Via Benzinga

Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

October 13, 2023

Via Benzinga

Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity ↗

November 07, 2023

Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month...

Via Benzinga

S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto ↗

November 07, 2023

Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-cap earnings reports gain momentum.

Via Benzinga

Topics Economy Stocks

Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets ↗

November 03, 2023

Markets bounced back decisively this week, shrugging off prior volatile months marked by heightened geopolitical tensions. The resurgence of risk sentiment ignited a relief rally in both equities and...

Via Benzinga

Topics Bonds Economy

Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today ↗

October 05, 2023

Via Benzinga

Leidos Sees Robust Demand In Digital Modernization, Raises Annual Outlook ↗

October 31, 2023

Leidos Holdings, Inc (NYSE: LDOS) reported third-quarter FY23 revenue growth of 9% year-over-year to $3.92 billion, beating the consensus of $3.77 billion.

Via Benzinga

3 Pharma Stocks That Are Screaming Buys in October ↗

October 26, 2023

Each company delivers an above-average dividend and revenue growth.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 24, 2023

Via Benzinga

7 Healthcare Stocks to invest in for a Healthy Future ↗

October 20, 2023

Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.

Via InvestorPlace

Pfizer Decides To Raise COVID-19 Treatment Pill Price, Defends Itself Amid Criticism for Cost Increase ↗

October 19, 2023

Pfizer Inc (NYSE: PFE) is reportedly gearing up to price its Covid-19 drug Paxlovid at $1,390 for a five-day course, more than double what the U.S. government initially paid for it, at $529.

Via Benzinga

Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling ↗

October 19, 2023

The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Why AstraZeneca's Disappointing Lung Cancer Update Also Tripped Gilead Stock ↗

October 18, 2023

The companies are hoping to use antibody drug conjugates in lung cancer patients.

Via Investor's Business Daily

Why Is Assembly Biosciences (ASMB) Stock Up 92% Today? ↗

October 17, 2023

Assembly Biosciences stock is taking off with heavy trading of ASMB shares after the company announced a new collaboration agreement!

Via InvestorPlace

Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why ↗

October 17, 2023

Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership.

Via Benzinga

2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now ↗

October 15, 2023

These companies aren't getting the respect they deserve.

Via The Motley Fool

A Bull Market Is Coming: 1 Beaten-Down Growth Stock You Could Regret Not Buying on the Dip ↗

October 10, 2023

Wall Street price targets suggest this stock can rocket more than 400% higher.

Via The Motley Fool

Biotech Sector: On The Verge Of Triumph Or Turmoil? ↗

October 06, 2023

In this article, we delve into the Biotech Sector, exploring its promises, potential pitfalls, and the questions that arise.

Via Talk Markets

Pharma Giants Combine Forces to Fight New M&A Rules ↗

October 04, 2023

Some of pharma's biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.

Via The Motley Fool

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs ↗

October 02, 2023

CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

Via InvestorPlace

3 Magnificent Dividend Stocks to Buy in October ↗

September 30, 2023

These stocks come with great dividends and more.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 29, 2023

Via Benzinga

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

49 50 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.